IDX
INTEGRAL DIAGNOSTICS ORDINARYIntegral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.
IDX
IDX
INTEGRAL DIAGNOSTICS ORDINARY
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 1.40% | — |
| 10 July | 1.40% | — |
| 9 July | 1.40% | — |
| 8 July | 1.37% | — |
| 7 July | 1.38% | — |
| 6 July | 1.40% | — |
| 3 July | 1.44% | — |
| 2 July | 1.45% | — |
| 1 July | 1.49% | — |
Integral Diagnostics (IDX) Short Interest Summary
Integral Diagnostics (IDX) currently has 1.40% of its shares sold short (5.2 million shares, worth approximately $11.1 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes IDX the #200 most shorted stock on the ASX most shorted list. Short interest in IDX is down 0.01% over the past week and down 0.71% over the past month. IDX is part of the Health Care sector on the ASX.
Recent IDX Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 1.40% | 5.2M | $2.08 |
| 10 July 2026 | 1.40% | 5.2M | $2.06 |
| 9 July 2026 | 1.40% | 5.2M | $2.08 |
| 8 July 2026 | 1.37% | 5.1M | $2.05 |
| 7 July 2026 | 1.38% | 5.2M | $2.10 |
| 6 July 2026 | 1.40% | 5.2M | $2.06 |
| 3 July 2026 | 1.44% | 5.4M | $2.02 |
| 2 July 2026 | 1.45% | 5.4M | $2.01 |
| 1 July 2026 | 1.49% | 5.5M | $2.01 |
| 30 June 2026 | 1.53% | 5.7M | $2.00 |
IDX Short Selling — Frequently Asked Questions
What is Integral Diagnostics (IDX)'s current short interest?
Integral Diagnostics (IDX) currently has a short interest of 1.40% of total shares outstanding. This means 1.40% of IDX's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is IDX heavily shorted on the ASX?
IDX has a relatively low short interest of 1.40%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for IDX investors?
Short interest in IDX shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 1.40%, IDX's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this IDX short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for IDX.